As of January 22, 2025, Sagimet Biosciences (SGMT) has a market cap of $0.14 billion USD. According to our data, Sagimet Biosciences is ranked No.7456 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.14 B |
-0.87%
|
Dec 31, 2024 | $0.14 B |
-16.97%
|
Dec 29, 2023 | $0.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Madrigal Pharmaceuticals
MDGL
|
$7.08 B |
-0.000 M
|
USA
|
Viking Therapeutics
VKTX
|
$3.79 B |
-0.000 M
|
USA
|
Akero Therapeutics
AKRO
|
$1.75 B |
0.000 M
|
USA
|
Galmed Pharmaceuticals
GLMD
|
$4.72 M |
0.000 M
|
Israel
|
89bio
ETNB
|
$0.79 B |
0.000 M
|
USA
|
Terns Pharmaceuticals
TERN
|
$0.40 B |
-0.000 M
|
USA
|
Genfit
GNFT
|
$0.18 B |
-0.000 M
|
France
|
Lipocine
LPCN
|
$23.48 M |
0.000 M
|
USA
|
Market Cap | = | SGMT Stock Price | * | SGMT Shares Outstanding |
= | $4.25 | * | 30.67 M | |
= | $0.14 B |